Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667040 · ClinicalTrials.gov registry record · NA
E-health Resilience Program For Chronic Spine Pain
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03667040: Clinical Trial NA study, sponsored by University of Michigan.
NCT03667040 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667040, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will examine a e-health resilience based program, JOOL, for chronic spine pain patients through the following aims: Aim 1: To test the effectiveness of a resilience based program known as JOOL Aim 2: To evaluate the characteristics of the participants most likely to benefit from this treatment
Primary Outcome
10 item survey measuring physical function. Each question is measured on a scale of 1-5. The lowest score being 10 and highest score is 50. A higher score correlates with poor physical functioning.
Interventions
- BEHAVIORAL JOOL app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-08-09 |
| Est. Completion | 2019-03-15 |
| Phase | NA |
Why NCT03667040 stopped before completion
NCT03667040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which JOOL app is the first listed.
NCT03667040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03667040 about?
NCT03667040 is a clinical study titled "E-health Resilience Program For Chronic Spine Pain". This study will examine a e-health resilience based program, JOOL, for chronic spine pain patients through the following aims: Aim 1: To test the effectiveness of a resilience based program known as JOOL Aim 2: To evaluate the characteristics of the participants most likely to benefit from this tre...
What is the current status of trial NCT03667040?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-08-09. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03667040?
The interventions under investigation include: JOOL app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03667040?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03667040's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI